about
Angioedema due to losartanThe role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease.Risk-benefit assessment of angiotensin II receptor antagonists.ORAL ADVERSE DRUG REACTIONS TO CARDIOVASCULAR DRUGS.Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment.Losartan in cardiovascular disease.Managing blood pressure control in Asian patients: safety and efficacy of losartan.Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.Valsartan-induced angioedema.The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.Angioedema associated with candesartan.Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy.Episodic macroglossia as the sole manifestation of angiotensin-converting enzyme inhibitor-induced angioedema.Treatment of angiotensin receptor blocker-induced angioedema: A case series.A case of idiopathic angioedema exacerbated by angiotensin receptor blocker administration.
P2860
Q28373043-8B4B1DBC-8141-4E6C-94A5-25981DA86BC0Q33852836-4A8BB0C4-FD09-4E8C-B7CC-7CFAAB7F4244Q33895248-945B62DC-19D8-48E1-8B3A-C6BEF71178B7Q35065532-6283A973-FEE3-4AEF-AB2F-4605A0923F8BQ35194507-837333B8-4751-4153-BFB3-C7E2127FB6E5Q35648448-CA216D58-64DB-4710-A32A-F701C528850CQ36753267-A3361809-2671-451D-9B81-3D41BF387FFFQ37608510-964837CD-ACC3-46F2-AED8-B411EC923EB5Q37659693-47C2C256-AA37-4850-8D07-89FCA8A69F3CQ41989294-2D791509-63DD-4B07-9EAC-E283B3B6EBA7Q42166125-8161D54A-1ADB-4A01-8ACE-7683651C108CQ43594877-7C6F9C26-6D35-431A-898B-B1741F5D22CBQ44131801-83C0DDEB-176D-4B63-BF9E-3B6F61D38A01Q44131804-279E1AD1-5804-4AB4-9FF2-A08F58D2E298Q44235911-1239770D-DF73-4207-A36C-3F003AD27B00Q44821211-F1037372-30E8-4EAB-AA8C-4665E018D9DDQ53621000-322D49E9-2D31-4516-8658-50844532EB96Q54517049-5923B3C3-8C06-4AF8-B0F4-E6C1791F7F5F
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Angioneurotic edema attributed to the use of losartan.
@en
Angioneurotic edema attributed to the use of losartan.
@nl
type
label
Angioneurotic edema attributed to the use of losartan.
@en
Angioneurotic edema attributed to the use of losartan.
@nl
prefLabel
Angioneurotic edema attributed to the use of losartan.
@en
Angioneurotic edema attributed to the use of losartan.
@nl
P2093
P1476
Angioneurotic edema attributed to the use of losartan.
@en
P2093
Feenstra J
Kwee-Zuiderwijk WJ
van Rijnsoever EW
P304
P356
10.1001/ARCHINTE.158.18.2063
P407
P577
1998-10-01T00:00:00Z